Vulcan Two Group (LSE:VUL) has appointed Declan Lismore as Chief Pharmacy Officer, adding senior regulated-pharmacy leadership as the group works to build out its buy-and-build ePharmacy platform.
The AIM-listed company completed the acquisitions of CloudRx, Webmed and Hyperdrug in March, establishing a platform spanning business-to-business prescription fulfilment and business-to-consumer digital pharmacy services.
Lismore brings experience from several online pharmacy businesses, having served as Director of Pharmacy at Chemist4U and Chief Pharmacist at HeliosX Group, where he oversaw automation, regulation and patient safety.
He also held the roles of Quality and Compliance Director and Superintendent Pharmacist at LloydsDirect, where he was part of the executive team that managed the sale of the business from Aurelius to Pharmacy2U.
In his new role, Lismore will oversee the group's dispensing operations, pharmacy compliance and regulatory relations.
"I have long believed that online and distance selling pharmacy can widen patient access to medicines when it is built on strong clinical governance and a commitment to patient safety," Lismore said.
Chief Executive Michael Kraftman said Lismore's appointment further strengthens the leadership team with deep sector expertise as the group continues to grow.
